Our mission is to help clients accelerate innovation by using our unique deep learning solutions to extract valuable information from existing processes and data.
Our technology originated from the work of Dr Gareth Conduit and collaborators at the Cavendish Laboratory, University of Cambridge. At Intellegens, we have further developed this work to build a unique Artificial Intelligence (AI) toolset that can train deep neural networks from sparse or noisy data. These capabilities are available through our first commercial product, Alchemite™. Our Cambridge-based development team continues to extend and improve the Alchemite™ software based on feedback from our customers and partners.
Our Alchemite™ tools can help with any problem where you need to understand and apply sparse and noisy data – from business decision-making to healthcare delivery. A key focus has been on problems in discovery and development, particularly where there is a need to focus or apply results from experimental programs in order to innovate, faster and at lower cost. From the first use of our algorithms on designing a novel alloy for aerospace applications, we’ve gone on to tackle applications in areas including formulation design, chemicals, drug discovery, materials, batteries, and optimising manufacturing processes.
Partnerships - embedding Intellegens technology
As well as providing value to our customers through the Alchemite™ software products, our deep learning technology can be embedded in third party platforms to help with problems related to sparse and noisy data. We have ongoing partnerships in areas from additive manufacturing to design of battery systems. The first commercially-released product to incorporate Alchemite™ technology is the Cerella™ drug discovery platform from our partner, Optibrium.